These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 18721166)
1. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166 [TBL] [Abstract][Full Text] [Related]
2. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833 [TBL] [Abstract][Full Text] [Related]
3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [TBL] [Abstract][Full Text] [Related]
4. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease. Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats]. Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890 [TBL] [Abstract][Full Text] [Related]
8. Predictors of non-alcoholic fatty liver disease in obese children. Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586 [TBL] [Abstract][Full Text] [Related]
9. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Ciba I; Widhalm K Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Panahi Y; Ghamarchehreh ME; Beiraghdar F; Zare R; Jalalian HR; Sahebkar A Hepatogastroenterology; 2012 Oct; 59(119):2099-2103. PubMed ID: 23234816 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582 [TBL] [Abstract][Full Text] [Related]
12. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding]. Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694 [TBL] [Abstract][Full Text] [Related]
13. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924 [TBL] [Abstract][Full Text] [Related]
16. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734 [TBL] [Abstract][Full Text] [Related]
17. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study. Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699 [TBL] [Abstract][Full Text] [Related]
18. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Askari F; Rashidkhani B; Hekmatdoost A Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315 [TBL] [Abstract][Full Text] [Related]
19. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Fu CC; Chen MC; Li YM; Liu TT; Wang LY Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666 [TBL] [Abstract][Full Text] [Related]
20. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY; Pan JQ; Lv JH Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]